Saratha Rajeswaran has joined the Association of the British Pharmaceutical Industry (ABPI) [Start date: Tuesday 30 May] as the new Executive Director of Government Affairs and Devolved Nations.
The Association of the British Pharmaceutical Industry (ABPI) have responded to today’s speech on the future of the UK’s relationship with the European Union (EU) by UK Prime Minister Theresa May at Santa Maria Novella, Florence, Italy.
The Association of the British Pharmaceutical Industry (ABPI) has responded to the announcement that Theresa May will form a minority government following the 2017 UK General Election.
A unique partnership announced today by the pharmaceutical industry and Greater Manchester Health and Social Care Partnership will help the city region deliver its vision to be the safest and most effective place to receive medicines in the world – and cement its position on the global research and...
In a new snapshot survey of leading pharmaceutical businesses in the UK, companies have said that changes to the way the National Institute for Health & Care Excellence (NICE) and NHS England (NHSE) assess new medicines, coming in to effect today (1 April 2017), will decrease access to the...
Timely reporting of results from pharmaceutical company-sponsored clinical trials for newly approved medicines has reached the highest recorded level of 93%, according to a new study published in the peer-reviewed journal Current Medical Research and Opinion (CMRO).
The Association of the British Pharmaceutical Industry (ABPI) has developed a new tool to help build research relationships between the pharmaceutical industry and UK academics. Launched at the Francis Crick Institute in London [Monday 5 June], the Library of Initiatives for Novel Collaborations (...
Eleven associations representing the European and British life science industry, including the Association of the British Pharmaceutical Industry (ABPI), have today launched a joint policy document on the potential impact of the United Kingdom’s exit from the European Union.
New research published today [14 December] by the Association of the British Pharmaceutical Industry (ABPI) shows that the amount of capital invested alongside CVC into UK companies increased six-fold between 2010 and 2015, marking a fundamental shift in how start-up British biotech is funded.
Following an announcement from European Commission President Jean-Claude Juncker and Prime Minister Theresa May this morning [8 December] that ‘sufficient progress’ has been agreed on phase one of the Brexit negotiations, the ABPI has released the following statement.